These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20629226)

  • 1. Novel genetic findings applied to the clinic in type 2 diabetes.
    Florez JC
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():21-5. PubMed ID: 20629226
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics of type 2 diabetes. An overview.
    Groop L; Lyssenko V
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():34-7. PubMed ID: 20629229
    [No Abstract]   [Full Text] [Related]  

  • 3. Unraveling the causes of diabetes.
    Marx J
    Science; 2002 Apr; 296(5568):686-9. PubMed ID: 11976439
    [No Abstract]   [Full Text] [Related]  

  • 4. The genetics of NIDDM. An update.
    Elbein SC; Hoffman MD; Bragg KL; Mayorga RA
    Diabetes Care; 1994 Dec; 17(12):1523-33. PubMed ID: 7882830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early changes in the function of pancreatic beta cells and insulin pulsatility as predictors of type 2 diabetes].
    Pørksen N
    Diabetes Metab; 1999 Dec; 25 Suppl 7():14-6. PubMed ID: 10746005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comeback for the beta cells in the pathogenesis of diabetes].
    Mulder H
    Lakartidningen; 2010 Nov 10-16; 107(45):2796-800. PubMed ID: 21179864
    [No Abstract]   [Full Text] [Related]  

  • 7. Trans fatty acids, insulin resistance and diabetes.
    Thompson AK; Minihane AM; Williams CM
    Eur J Clin Nutr; 2011 May; 65(5):553-64. PubMed ID: 20978530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances.
    Florez H; Ryder E; Campos G; Fernandez V; Morales LM; Valbuena H; Rincón E; Gómez ME; Raleigh X
    Invest Clin; 1999 Jun; 40(2):127-42. PubMed ID: 10390951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From obesity to diabetes or the natural history of abnormalities in the secretion and action of insulin].
    Scheen AJ
    Rev Med Liege; 1992 Jul; 47(7):325-37. PubMed ID: 1636074
    [No Abstract]   [Full Text] [Related]  

  • 10. [What have we learned thanks to genetics in type II diabetes and its complications?].
    Froguel P
    Nephrologie; 1999; 20(2):59-63. PubMed ID: 10227025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and hyperinsulinaemia in insulin receptor substrate-1 knockout mice.
    Jenkins AB; Storlien LH
    Diabetologia; 1997 Sep; 40(9):1113-4. PubMed ID: 9300252
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin secretion in type 2 diabetes: clinical aspects.
    Boitard C
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S33-8. PubMed ID: 12703063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INS VNTR class genotype and the function of isolated human islets.
    D'Aleo V; Del Guerra S; Groves C; Lupi R; Tancredi M; McCarthy M; Marchetti P
    Nutr Metab Cardiovasc Dis; 2011 Mar; 21(3):e9-11. PubMed ID: 21193298
    [No Abstract]   [Full Text] [Related]  

  • 14. The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children.
    Sentinelli F; Bertoccini L; Barchetta I; Capoccia D; Incani M; Pani MG; Loche S; Angelico F; Arca M; Morini S; Manconi E; Lenzi A; Cossu E; Leonetti F; Baroni MG; Cavallo MG
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):407-13. PubMed ID: 27052925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease.
    Terauchi Y; Iwamoto K; Tamemoto H; Komeda K; Ishii C; Kanazawa Y; Asanuma N; Aizawa T; Akanuma Y; Yasuda K; Kodama T; Tobe K; Yazaki Y; Kadowaki T
    J Clin Invest; 1997 Mar; 99(5):861-6. PubMed ID: 9062343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 17. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
    Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
    J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin secretion in non-insulin-dependent diabetes].
    Turner RC; Clark A; Levy J; Hattersley AT; Cook JC
    Journ Annu Diabetol Hotel Dieu; 1991; ():141-51. PubMed ID: 1909394
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular pathogenesis of type 2 diabetes mellitus].
    Kadowaki T
    Seikagaku; 1999 Nov; 71(11):1281-98. PubMed ID: 10614177
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 2 diabetes: hypoinsulinism, hyperinsulinism, or both?
    Glaser B
    PLoS Med; 2007 Apr; 4(4):e148. PubMed ID: 17407388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.